$CLNN Income Statement | Understand Stock

$CLNN

$3.97 +$0.13 (3.39%) Close

$CLNN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Product
Royalty
Total revenue
Cost of revenue
Operating expenses:
Cost of revenue
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense), net:
Interest income
Gain on extinguishment of notes payable
Loss on extinguishment of convertible notes payable
Gain on termination of lease
Change in fair value of preferred stock warrant liability
Change in fair value of common stock warrant liability
Change in fair value of derivative liability
Interest expense
Loss on extinguishment of notes payable
Notes Payable to Banks
Total loss on extinguishment of notes payable

Commitment share expense
Issuance costs for common stock warrant liabilities
Loss on initial issuance of equity
Change in fair value of common stock warrant liabilities
Change in fair value of derivative liabilities
Change in fair value of Clene Nanomedicine contingent earn-out liability
Change in fair value of Initial Stockholders contingent earn-out liability
Australia research and development credit
Research and development tax credits and unrestricted grants
Other expense, net
Total other income (expense), net
Net loss before income taxes
Income tax expense
Net loss

Other comprehensive income (loss):
Unrealized loss on available-for-sale securities
Foreign currency translation adjustments
Total other comprehensive income (loss)
Comprehensive loss
Net loss per share-- basic and diluted (Note 19) (in Dollars per share)
Net loss per share – basic and diluted (in dollars per share)
Weighted average common shares used to compute basic and diluted net loss per share (in shares)

Comments